Risk factor
Very poor trading liquidity
Profitability factor
Excellent dividends
About
Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin pills and oral liquid nutrients; trading, wholesale, and retail of medical drugs and medical equipment; wholesale and retail sales of food, baby products, and general food products; and wholesale trading and agency business. It also provides consulting and analysis; warehousing services; and mother and baby skin care products under the Mustela brand. In addition, the company provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. Maywufa Company Ltd. was incorporated in 1976 and is headquartered in Taipei, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on